BioXcel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.18	28.76	29.85	65.22	193.73	232.97
Cash & Short-Term Investments	17.18	28.76	29.85	65.22	193.73	232.97
Cash Growth	-44.60%	-3.67%	-54.23%	-66.33%	-16.84%	9.31%
Accounts Receivable	0.22	0.23	0.13	0.07	0.25	-
Inventory	0.5	0.72	0.68	1.99	1.99	-
Other Current Assets	16.01	14.97	6.73	4.86	6.91	3.84
Total Current Assets	33.91	44.69	37.39	72.14	202.87	236.81
Net Property, Plant & Equipment	0.12	0.23	0.86	1.47	2.06	2.54
Other Long-Term Assets	-	-	0.09	0.09	0.93	0.09
Total Assets	34.03	44.92	38.34	73.7	205.85	239.44
Accounts Payable	16.25	14.7	15.99	13.65	10.23	4.68
Accrued Expenses	6.39	4.34	5.76	13.16	21.84	11.49
Current Portion of Long-Term Debt	22.43	24.93	-	-	-	-
Other Current Liabilities	9.93	9.95	0.48	0.45	0.83	0.5
Total Current Liabilities	54.99	53.93	22.23	27.27	32.9	16.67
Long-Term Debt	77.86	84.66	102.51	100.6	93.05	-
Long-Term Leases	-	-	0.07	0.44	0.79	1.11
Other Long-Term Liabilities	6.72	1.79	6.63	1.91	2.34	-
Total Long-Term Liabilities	84.57	86.45	109.21	102.94	96.18	1.11
Total Liabilities	139.57	140.38	131.44	130.21	129.08	17.77
Common Stock	0.03	0.08	0.05	0.03	0.03	0.03
Additional Paid-in Capital	627.22	624.56	557.05	534.06	488.29	467.43
Retained Earnings	-732.79	-720.09	-650.2	-590.6	-411.55	-245.79
Shareholders' Equity	-105.54	-95.46	-93.1	-56.51	76.78	221.67
Total Liabilities & Equity	34.03	44.92	38.34	73.7	205.85	239.44
Total Debt	100.29	109.59	102.57	101.04	93.84	1.11
Net Cash (Debt)	-83.11	-80.84	-72.72	-35.82	99.89	231.86
Net Cash Growth	-	-	-	-	-56.92%	9.51%
Net Cash Per Share	-4.93	-6.62	-28.69	-19.67	57.05	140.67
Book Value	-105.54	-95.46	-93.1	-56.51	76.78	221.67
Book Value Per Share	-6.26	-7.82	-36.73	-31.03	43.85	134.48
Tangible Book Value	-105.54	-95.46	-93.1	-56.51	76.78	221.67
Tangible Book Value Per Share	-6.26	-7.82	-36.73	-31.03	43.85	134.48

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q